Goeldlin, Martina http://orcid.org/0000-0001-5800-116X
Gaschen, Janika
Kammer, Christoph
Comolli, Lukas
Bernasconi, Corrado A.
Spiegel, Rainer
Bassetti, Claudio L.
Exadaktylos, Aristomenis K.
Lehmann, Beat
Mantokoudis, Georgios
Kalla, Roger
Fischer, Urs
Funding for this research was provided by:
Gottfried und Julia Bangerter-Rhyner-Stiftung (YTCR 13/18)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (320030_173081)
Article History
Received: 23 April 2019
Revised: 26 July 2019
Accepted: 3 September 2019
First Online: 17 September 2019
Compliance with ethical standards
:
: This was an investigator-initiated study with no external sponsorship. M. Goeldlin’s work is supported by a “Young Talents in Clinical Research” Grant by the SAMW/Bangerter-Rhyner foundation (Grant YTCR_13/18). Dr. Bernasconi has received consulting fees from Roche, Santhera, AC Immune and PresSura Neuro. Dr. Kalla and Dr. Mantokoudis were supported by the Swiss National Science Foundation (Grant #320030_173081). Dr. Fischer is a consultant for Medtronic, Stryker and CSL Behring. He is the Co-PI of the SWIFT DIRECT trial (supported by Medtronic). He receives research grants from the Swiss Heart Foundation and the Swiss National Science Foundation.
: The study was approved by the local ethics committee and was conducted in accordance with the Declaration of Helsinki. Given the retrospective nature of the study, informed consent was provided through a hospital-wide general consent. However, patients who withdrew consent for evaluation of their medical data had to be excluded in accordance with legal requirements.